wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37432086-B4870E58-1C13-4A45-9169-8F2CF0BD7973
Q37432086-B4870E58-1C13-4A45-9169-8F2CF0BD7973
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37432086-B4870E58-1C13-4A45-9169-8F2CF0BD7973
Chronic hepatitis B: who to treat and which choice of treatment?
P2860
Q37432086-B4870E58-1C13-4A45-9169-8F2CF0BD7973
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37432086-B4870E58-1C13-4A45-9169-8F2CF0BD7973
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
aae9831c2caf15234da5a26caad99db3b47b16aa
P2860
2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B.